Loan agreement

Oxurion Announces Key Amendments to Atlas and Kreos/Pontifax Agreements Enabling KALAHARI Trial to Progress to Topline Results in 2023

Retrieved on: 
Monday, September 11, 2023
CFA, Privacy and Civil Liberties Oversight Board report on mass surveillance, DME, Diabetic retinopathy, Atlas, Paratriathlon, Prospectus, Loan agreement, Subscription business model, Patient, Brussels Stock Exchange, Convertible, Issuer, Loan, Disease, Security (finance), Credit

Atlas has agreed to waive the market capitalization and liquidity conditions for up to €3.5 million in mandatorily convertible bonds.

Key Points: 
  • Atlas has agreed to waive the market capitalization and liquidity conditions for up to €3.5 million in mandatorily convertible bonds.
  • The amount of the monthly payments, which will be made mid-month, shall not be reduced; rather, the Loan Agreement shall be repaid more quickly.
  • Tom Graney, CFA, CEO of Oxurion, said: “We greatly appreciate the vote of confidence that our partners, Atlas and Kreos/Pontifax, have shown Oxurion through these financial commitments enabling Oxurion to progress the Phase 2, Part B KALAHARI trial of THR-149 in Diabetic Macular Edema (DME), to the topline results later this year.
  • We are eager to share the expected topline data from the KALAHARI trial of THR-149, which holds the exciting potential of addressing this large unmet need and attractive market later this year.”

IntelGenx Announces Closing of First Tranche of Non-Brokered Private Placement From Strategic Partner for Approximate Aggregate Gross Proceeds of US$3 Million (Including US$750,000 to be Received by the Company Once Shareholder Approvals Have Been Obtaine

Retrieved on: 
Thursday, August 31, 2023
Call option, Acquisition, Used note, Toronto Stock Exchange, Loan, Loan agreement, Second, Minority, IGX, Related, Customary international law, National instrument, Offering, Useful conversions and formulas for air dispersion modeling, TSX, Security (finance), Multilateral, Bankruptcy, Exercise, Constitutional right, Condition subsequent, Berlin, Call, Government patent use (United States), MI, Option style, CDN, Shareholder, Sale, Initial, Subscription business model, Life insurance, Unit, Share (finance), Warrant, Note, Corporation

atai, a significant shareholder and partner of the Company, subscribed, on the date hereof, for 2,220 US Units for aggregate gross proceeds to the Company of US$2,220,000 (the “Initial atai Proceeds”).

Key Points: 
  • atai, a significant shareholder and partner of the Company, subscribed, on the date hereof, for 2,220 US Units for aggregate gross proceeds to the Company of US$2,220,000 (the “Initial atai Proceeds”).
  • The Corporation will seek to obtain the Shareholder Approvals at an upcoming special meeting of Shareholders to be held as soon as practicable after the date hereof.
  • An early warning report will be filed under the Company’s profile on the SEDAR+ website at www.sedarplus.ca.
  • This press release does not constitute an offer of securities for sale in the United States.

LumiraDx Reports Second Quarter 2023 Results

Retrieved on: 
Thursday, August 24, 2023
Ninth Amendment, Marketing, Ninth, Amendment, Food, Research, Pharmacy, Loan agreement, Webcast, POC, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, Pharmaceutical industry, Video game, Reinsurance, Security (finance)

LONDON, Aug. 24, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (NASDAQ: LMDX), a next-generation point of care (POC) diagnostics company, today announced financial results for its second quarter ended June 30, 2023.

Key Points: 
  • LONDON, Aug. 24, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (NASDAQ: LMDX), a next-generation point of care (POC) diagnostics company, today announced financial results for its second quarter ended June 30, 2023.
  • In addition, we are seeing revenues from our non-COVID products continue to grow, with the second quarter marking our highest quarter to date for non-COVID revenues.
  • Non-COVID specific revenues in the second quarter of 2023 were $9.2 million, or 44% of total revenues, including $4.4 million of LumiraDx technology revenues and $4.8 million of distribution revenues.
  • Research and development expenses were $15.8 million in the second quarter of 2023.

Optimi Health Announces CAD $3,000,000 Senior Debt Financing

Retrieved on: 
Thursday, August 10, 2023
GMP, Minority, CSE, GSA, MI, CAD, FRA, Wilson, Loan agreement, Debt, Warrant, Growth, Loan, Health Canada, MDMA, Security (finance)

The company has already brought in the first tranche of CAD $1,000,000 from Catcher Investments Ltd., a company under the stewardship of Mr. JJ Wilson, who also serves as a director and non-executive Chair of Optimi Health.

Key Points: 
  • The company has already brought in the first tranche of CAD $1,000,000 from Catcher Investments Ltd., a company under the stewardship of Mr. JJ Wilson, who also serves as a director and non-executive Chair of Optimi Health.
  • The Debt Financing Agreement and GSA were approved by the independent members of the Company’s board of directors.
  • Optimi CFO Jacob Safarik announced that the company plans to allocate the funding towards scaling its operations and fulfilling its on-going supply agreements.
  • Combined with the forecasted revenue, this financing puts Optimi on a path to achieving positive EBITDA.”
    FOR INTERVIEW REQUESTS OR FURTHER INFORMATION PLEASE CONTACT:

Casella Waste Systems, Inc. Announces Pricing of Up to $35.0 Million of New York State Environmental Facilities Corporation Solid Waste Disposal Revenue Bonds (Casella Waste Systems, Inc. Project) Series 2020R-2

Retrieved on: 
Wednesday, August 9, 2023
SEC Rule 144A, Recycling, Sale, Loan agreement, Municipal solid waste, Surety, Guarantee, Security (finance), Bond, Casella, Issuer

The issuance of the Bonds is expected to close on August 24, 2023.

Key Points: 
  • The issuance of the Bonds is expected to close on August 24, 2023.
  • Casella intends to use the net proceeds of the Bonds to finance and/or reimburse certain costs of certain capital projects in the State of New York.
  • Casella cannot guarantee that it actually will achieve the plans, intentions, expectations or guidance disclosed in the forward-looking statements made.
  • There can be no assurance that Casella will be able to complete the closing of the offering of the Bonds on the anticipated terms, or at all.

Perma-Fix Reports 29% Increase in Revenue to $25 Million for the Second Quarter of 2023

Retrieved on: 
Thursday, August 3, 2023
U.S. Department of Energy, Office of Inspector General, Engineer, U.S. Army Corps of Engineers, Europe District, U.S. Department of Defense Strategy for Operating in Cyberspace, Service, COVID-19, Tax, Los Alamos National Laboratory, GAAP, Corps, DOE, Ecosystem, DOD, EBITDA, PESI, Depreciation, Loan agreement, Video game, Bookkeeping

Specifically, revenue increased 28.7% to $25.0 million and we achieved a 56.6% increase in gross profit over the same period last year.

Key Points: 
  • Specifically, revenue increased 28.7% to $25.0 million and we achieved a 56.6% increase in gross profit over the same period last year.
  • Revenue for the Treatment Segment was approximately $12.8 million for the second quarter of 2023 as compared to $8.4 million for the second quarter 2022.
  • Gross profit for the second quarter of 2023 was $4.5 million versus $2.9 million for the second quarter of 2022 primarily due to higher revenue generated in both segments.
  • Operating income for the second quarter of 2023 was approximately $844,000 versus operating loss of $880,000 for the second quarter of 2022.

Casella Waste Systems, Inc. Announces Offering of New York State Environmental Facilities Corporation Solid Waste Disposal Revenue Bonds

Retrieved on: 
Tuesday, August 1, 2023
SEC Rule 144A, Recycling, Electric Bond and Share Company v. Securities and Exchange Commission, Sale, Loan agreement, Municipal solid waste, Security (finance), Surety, Guarantee, Bond, Casella, Issuer

RUTLAND, Vt., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Casella Waste Systems, Inc. (“Casella”) (NASDAQ:CWST), a regional solid waste, recycling and resource management services company, today announced an offering of up to $35.0 million aggregate principal amount of New York State Environmental Facilities Corporation (the “Issuer”) Solid Waste Disposal Revenue Bonds (Casella Waste Systems, Inc. Project) Series 2020R-2 (the “Bonds”) under an indenture between the Issuer and the bond trustee, dated as of September 1, 2020 (the “Indenture”).

Key Points: 
  • RUTLAND, Vt., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Casella Waste Systems, Inc. (“Casella”) (NASDAQ:CWST), a regional solid waste, recycling and resource management services company, today announced an offering of up to $35.0 million aggregate principal amount of New York State Environmental Facilities Corporation (the “Issuer”) Solid Waste Disposal Revenue Bonds (Casella Waste Systems, Inc. Project) Series 2020R-2 (the “Bonds”) under an indenture between the Issuer and the bond trustee, dated as of September 1, 2020 (the “Indenture”).
  • The Bonds represent the drawdown (which would no longer be available to the Company if not occurring by September 2, 2023) of the remainder of the New York State Environmental Facilities Corporation Solid Waste Disposal Revenue Bonds Series 2020, the initial proceeds of which, in the amount of $40.0 million, were issued in September 2020.
  • Casella intends to use the net proceeds of the Bonds to finance and/or reimburse Casella for certain costs of certain capital projects in the State of New York.
  • The exact terms and timing of the offering of the Bonds will depend upon market conditions and other factors.

InspireSemi Announces Closing of Second Tranche of Private Placement and Amendment to Loan Agreement

Retrieved on: 
Wednesday, June 28, 2023
Unit, Minority, Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., TSX Venture Exchange, MI, Private placement, Private, Placement, Loan agreement, Creditor, Loan, Amendment, Security (finance)

Total proceeds raised as part of the second tranche of the Private Placement were C$1,537,000.

Key Points: 
  • Total proceeds raised as part of the second tranche of the Private Placement were C$1,537,000.
  • All securities issued pursuant to the closing of the second tranche of the Private Placement are subject to resale restrictions pursuant to applicable securities law requirements until October 29, 2023.
  • Pursuant to the Amendment the existing loans made under the Loan Agreement now have the same terms as the securities issued in the Private Placement, such that the lenders under the Loan Agreement have been issued Units.
  • Following the completion of the Amendment no further funds are available to the Company pursuant to the Loan Agreement.

EQONEX SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eqonex To Contact Him Directly To Discuss Their Options

Retrieved on: 
Saturday, June 17, 2023
Qualification, LLP, Asset management, Partnership, Woman, Exchange, Multimedia, Loan agreement, Advertising, OTC, FCA, Court, Defendant, Loan, News, Cryptocurrency, Custody, Binance

If you suffered losses exceeding $100,000 investing in Eqonex stock or options between March 7, 2022 and November 29, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.

Key Points: 
  • If you suffered losses exceeding $100,000 investing in Eqonex stock or options between March 7, 2022 and November 29, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.
  • Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding Equonix's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

EQUONEX SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eqonex To Contact Him Directly To Discuss Their Options

Retrieved on: 
Saturday, June 10, 2023
Qualification, LLP, Asset management, Partnership, Woman, Exchange, Multimedia, Loan agreement, Advertising, OTC, FCA, Court, Defendant, Loan, News, Cryptocurrency, Custody, Binance

If you suffered losses exceeding $100,000 investing in Eqonex stock or options between March 7, 2022 and November 29, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.

Key Points: 
  • If you suffered losses exceeding $100,000 investing in Eqonex stock or options between March 7, 2022 and November 29, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.
  • Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding Equonix's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.